Core Needle Biopsy Devices Market Analysis 2026

Global Core Needle Biopsy Devices Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends

Core Needle Biopsy Devices Market Report Description

We have various report editions of Core Needle Biopsy Devices Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Core Needle Biopsy Devices Market Insights Video

Competitive Landscape of the Core Needle Biopsy Device Market

The competitive landscape of the Core Needle Biopsy Device market is characterized by a diverse range of players, including established medical device manufacturers, specialized biotech companies, and emerging startups. Key industry participants are continuously investing in research and development to innovate and enhance the efficacy and safety of their products.

In Mar 2022, Hologic, Inc., an innovative medical technology company primarily focused on improving women’s health, opened its Innovation Center today in Aix-en-Provence, France. The new commercial office and training and research and development facility will support Hologic’s ultrasound, interventional, and surgical solutions across the continuum of breast health care . (Source: https://investors.hologic.com/press-releases/press-release-details/2022/Hologic-Opens-New-Innovation-Center-in-France/default.aspx) In April 2021, Unilabs and GE Healthcare signed a partnership agreement. GE Healthcare provides technically advanced MRIs and CT scanning technology, ultrasound devices, mammography, and X-ray machines to Unilabs in Portugal. (Source: https://www.gehealthcare.com/about/newsroom/press-releases/unilabs-and-ge-healthcare-launch-partnership-for-latest-radiology-equipment-and?npclid=botnpclid)

Top Companies Market Share in Core Needle Biopsy Devices Industry: (In no particular order of Rank)

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive)

Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Core Needle Biopsy Device Market

Which Region Dominates the Core Needle Biopsy Device Market in 2024?

According to Cognitive Market Research, North America dominates the Core Needle Biopsy Device market due to several key factors. The region boasts advanced healthcare infrastructure, high prevalence of cancer, and increasing demand for minimally invasive diagnostic procedures. Technological innovations in biopsy devices, along with significant investments in research and development, further enhance market growth.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific region is the fastest-growing market for Core Needle Biopsy Devices due to several factors driving rapid expansion. Increasing incidences of cancer, particularly breast and lung cancers, have heightened the demand for effective diagnostic tools. Rapid urbanization and improving healthcare infrastructure in countries like China and India are enhancing access to advanced medical technologies.

The current report Scope analyzes Core Needle Biopsy Devices Market on 6 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (East Africa, West Africa, North Africa, South Africa)

The above graph is for illustrative purposes only.

North America Core Needle Biopsy Devices Market Analysis

According to Cognitive Market Research, the global Core Needle Biopsy Device market size was estimated at USD 6854.5 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 2741.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 13.4% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Core Needle Biopsy Device market with a market size of USD 2163.28 million in 2024 and is projected to grow at a CAGR of 13.2% during the forecast period. The U.S. market's increasing prevalence of cancers and advancements in biopsy techniques.
• The Canada Core Needle Biopsy Device market had a market share of USD 329.02 million in 2024 and is projected to grow at a CAGR of 14.2% during the forecast period. Canada’s increasing prevalence of cancers and advancements in biopsy techniques.
• The Mexico Core Needle Biopsy Device market is projected to witness growth at a CAGR of 13.9% during the forecast period, with a market size of USD 249.50 million in 2024.

Europe Core Needle Biopsy Devices Market Analysis

According to Cognitive Market Research, the global Core Needle Biopsy Device market size was estimated at USD 6854.5 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 2056.35 million in 2024 and will grow at a compound annual growth rate (CAGR) of 13.7% from 2024 to 2031.

• The United Kingdom Core Needle Biopsy Device market had a market share of USD 345.47 million in 2024 and is projected to grow at a CAGR of 14.5% during the forecast period. In the UK, Core Needle Biopsy Device sales witness an upswing due to the owing to the growing emphasis on sustainability.
• The France Core Needle Biopsy Device market is projected to witness growth at a CAGR of 12.9% during the forecast period, with a market size of USD 189.18 million in 2024.
• According to Cognitive Market Research, the German Core Needle Biopsy Device market size was valued at USD 407.16 million in 2024 and is projected to grow at a CAGR of 13.9% during the forecast period. In Germany, Core Needle Biopsy Device surged due to the owing to the growing emphasis on sustainability.
• The Italy Core Needle Biopsy Device market is projected to witness growth at a CAGR of 13.1% during the forecast period, with a market size of USD 176.85 million in 2024.
• The Russia Core Needle Biopsy Device market is projected to witness growth at a CAGR of 12.7% during the forecast period, with a market size of USD 318.73 million in 2024.
• The Spain Core Needle Biopsy Device market is projected to witness growth at a CAGR of 12.8% during the forecast period with a market size of USD 168.62 million in 2024
• The Luxembourg Core Needle Biopsy Device market is projected to witness growth at a CAGR of 13.8% during the forecast period, with a market size of USD 63.75 million in 2024.
• The Portugal Core Needle Biopsy Device market is projected to witness growth at a CAGR of 13.5% during the forecast period, with a market size of USD 43.18 million in 2024.
• The Greece Core Needle Biopsy Device market is projected to witness growth at a CAGR of 14.0% during the forecast period, with a market size of USD 24.68 million in 2024.
• The Rest of Europe's Core Needle Biopsy Device market is projected to witness growth at a CAGR of 12.4% during the forecast period, with a market size of USD 318.73 million in 2024.

Asia Pacific Core Needle Biopsy Devices Market Analysis

According to Cognitive Market Research, the global Core Needle Biopsy Device market size was estimated at USD 6854.5 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 1576.54 million in 2024 and will grow at a compound annual growth rate (CAGR) of 17.2% from 2024 to 2031.

• According to Cognitive Market Research, the China Core Needle Biopsy Device market size was valued at USD 709.44 million in 2024 and is projected to grow at a CAGR of 16.7% during the forecast period. Core Needle Biopsy Device surged in China due to increasing awareness of cancer screening.
• The Japan Core Needle Biopsy Device market is projected to witness growth at a CAGR of 15.7% during the forecast period, with a market size of USD 217.56 million in 2024.
• The India Core Needle Biopsy Device market had a market share of USD 189.18 million in 2024 and is projected to grow at a CAGR of 19.0% during the forecast period. India's increasing awareness of cancer screening .
• The South Korean Core Needle Biopsy Device market is projected to witness growth at a CAGR of 16.3% during the forecast period, with a market size of USD 157.65 million in 2024.
• The Australian Core Needle Biopsy Device market is projected to witness growth at a CAGR of 16.9% during the forecast period, with a market size of USD 81.98 million in 2024.
• The South East Asia Core Needle Biopsy Device market is projected to witness growth at a CAGR of 18.2% during the forecast period, with a market size of USD 108.78 million in 2024.
• The Rest of Asia Pacific Core Needle Biopsy Device market is projected to witness growth at a CAGR of 17.0% during the forecast period, with a market size of USD 111.93 million in 2024.

South America Core Needle Biopsy Devices Market Analysis

According to Cognitive Market Research, the global Core Needle Biopsy Device market size was estimated at USD 6854.5 Million, out of which the Latin America held the market share of around 5% of the global revenue with a market size of USD 342.73 million in 2024 and will grow at a compound annual growth rate (CAGR) of 14.6% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Core Needle Biopsy Device market size was valued at USD 146.69 million in 2024 and is projected to grow at a CAGR of 15.2% during the forecast period. Core Needle Biopsy Devices flourished in Brazil due to increasing incidence of cancer and a rising focus on early detection and diagnosis.
• Argentina's Core Needle Biopsy Device market had a market share of USD 57.58 million in 2024 and is projected to grow at a CAGR of 15.5% during the forecast period. Argentina's increasing incidence of cancer and a rising focus on early detection and diagnosis .
• Colombia Core Needle Biopsy Device market is projected to witness growth at a CAGR of 14.4% during the forecast period, with a market size of USD 30.50 million in 2024.
• Peru Core Needle Biopsy Device market is projected to witness growth at a CAGR of 14.8% during the forecast period, with a market size of USD 28.10 million in 2024.
• Chile Core Needle Biopsy Device market is projected to witness growth at a CAGR of 14.9% during the forecast period, with a market size of USD 24.68 million in 2024.
• The Rest of Latin America's Core Needle Biopsy Device market is projected to witness growth at a CAGR of 13.7% during the forecast period, with a market size of USD 55.18 million in 2024.

Middle East Core Needle Biopsy Devices Market Analysis

According to Cognitive Market Research, the global Core Needle Biopsy Device market size was estimated at USD 6854.5 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 137.09 million in 2024 and will grow at a compound annual growth rate (CAGR) of 14.9% from 2024 to 2031..

• The GCC Countries Core Needle Biopsy Device market is projected to witness growth at a CAGR of 15.7% during the forecast period, with a market size of USD 58.67 million in 2024. Core Needle Biopsy Device sales flourish due to the increasing cancer prevalence and a growing emphasis on diagnostic accuracy.
• The Egypt Core Needle Biopsy Device market is projected to witness growth at a CAGR of 15.2% during the forecast period, with a market size of USD 14.39 million in 2024.
• The South Africa Core Needle Biopsy Device market is projected to witness growth at a CAGR of 15.9% during the forecast period, with a market size of USD 21.66 million in 2024. Core Needle Biopsy Device sales flourished in South Africa due to increasing cancer prevalence and a growing emphasis on diagnostic accuracy.
• The Turkey Core Needle Biopsy Device market is projected to witness growth at a CAGR of 14.4% during the forecast period, with a market size of USD 11.79 million in 2024.
• The Nigeria Core Needle Biopsy Device market is projected to witness growth at a CAGR of 14.0% during the forecast period, with a market size of USD 14.39 million in 2024.
• The Rest of the MEA Core Needle Biopsy Device market is projected to witness growth at a CAGR of 13.9% during the forecast period, with a market size of USD 16.18 million in 2024.

Author's Conclusion

Author's Detail

Supriya Yadav

Research Analyst at Cognitive Market Research

LinkedIn | Profile | Book Appointment

Supriya Yadav is a skilled market researcher with strong expertise in the Medical Devices and Consumables industry. Known for her analytical precision and deep interest in healthcare innovation, she focuses on decoding key market trends, technological advancements, and evolving customer needs. Supriya excels at transforming complex industry data into meaningful insights that support strategic decision-making for healthcare stakeholders. Her commitment to understanding the future of medical technologies and improving patient-centric solutions makes her a valuable contributor in this rapidly advancing sector.